Quantcast

Got Stocks from QualityStocks Ones To Watch

Got Stocks

Find out which Small-Cap / Micro-Caps should be on your radar. Get the news and information that moves the markets this week and the "Ones to Watch", only at QualityStocks. The "Quality" is Back in Stocks...




Untitled Document

MRI Interventions, Inc. (MRIC)

MRI Interventions, Inc. is a commercial stage medical device company. It develops and commercializes distinct platforms for performing minimally invasive surgical procedures in the brain under direct, intra-procedural Magnetic Resonance Imaging, or MRI, guidance. Using a hospital's existing MRI suite, the design of its Food and Drug Administration (FDA)-cleared and CE-marked ClearPoint® system is to enable a range of minimally invasive procedures in the brain. Listed on the OTCQB, MRI Interventions has its headquarters in Irvine, California.

The company's emphasis is Magnetic Resonance Imaging (MRI)-Guided Neurosurgical procedures. The ClearPoint® system enables real-time MRI-guided navigation for a wide assortment of minimally-invasive neurosurgery procedures.

The platform is especially well-matched for facilitating drug delivery directly to brain tumors. The ClearPoint® system is the only navigation platform designed to allow real-time visualization during minimally-invasive neurosurgical procedures.

MRI Interventions has a co-development and co-distribution agreement with Brainlab, a leader in software-driven medical technology, regarding the ClearPoint® system. Furthermore, MRI Interventions is developing the ClearTrace® system in partnership with Siemens Healthcare. This is to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation.

ClearPoint® is an integrated system of hardware components, disposable components, and intuitive, menu-driven software. The ClearPoint® system provides MRI-based stereotactic guidance for the placement and operation of instruments or devices during the planning and operation of neurological procedures performed within the MRI suite. ClearPoint® procedures can be used with 1.5T and 3T scanners.

Recently, MRI Interventions announced the first brain tumor surgery in Minnesota performed utilizing the ClearPoint® Neuro Navigation System at the University of Minnesota Medical Center. University of Minnesota Health represents collaboration between University of Minnesota Physicians, Fairview Health Services, and University of Minnesota Medical Center.

MRI Interventions also recently commented on Voyager Therapeutics' announcement of FDA clearance of its Investigational New Drug (IND) application for VY-AADC. This is Voyager's gene therapy program targeting advanced Parkinson's disease. Clearance of the IND permits Voyager Therapeutics to formally start clinical trial sites and commence screening patients for its pivotal Phase 2-3 program.

Wendelin Maners, Vice President of Marketing and Clinical Operations at MRI Interventions, said, "We are excited that FDA cleared this IND, allowing commencement of Voyager's gene therapy pivotal program for advanced Parkinson's disease. This represents an important milestone in our own pipeline of gene therapy and drug delivery trials utilizing the ClearPoint® Neuro Navigation system and SmartFlow® drug delivery cannulas as the premier targeting platform for direct deployment of biologics to precise regions within the brain."

 

 

 

The QualityStocks
Newsroom

Read the articles covering the biggest movers in the markets today.

Continue

Market
Basics

Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks markets.

Continue

The QualityStocks Daily
Archives

Go back to see our previous newsletters and find out what you might have missed.

Continue